Kliniken Beelitz GmbH
Clinical Trials
11
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients
- Conditions
- Parkinson DiseaseMultiple System AtrophyProgressive Supranuclear Palsy
- First Posted Date
- 2021-12-01
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Kliniken Beelitz GmbH
- Target Recruit Count
- 75
- Registration Number
- NCT05139342
- Locations
- 🇩🇪
Movement Disorders Hospital - Kliniken Beelitz, Beelitz-Heilstätten, Brandenburg, Germany
🇩🇪Universitätsklinium Münster, Münster, Germany
🇩🇪Klinikum Osnabrück, Osnabrück, Germany
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
- Conditions
- Multiple System AtrophyParkinson DiseaseProgressive Supranuclear PalsyMotor Neuron DiseaseNeurodegenerative Diseases
- First Posted Date
- 2021-01-12
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Kliniken Beelitz GmbH
- Target Recruit Count
- 350
- Registration Number
- NCT04706234
- Locations
- 🇦🇹
Department of Neurology and Department of ENT, Medical University Innsbruck, Innsbruck, Tirol, Austria
🇩🇪Department of Neurology, Medical University of Ulm, Ulm, Baden-Württemberg, Germany
🇩🇪Movement Disorders Hospital - Kliniken Beelitz, Beelitz-Heilstätten, Brandenburg, Germany